In-utero exposures | Breast Cancer UK

In-utero exposures

What are in-utero exposures?

Although the womb is traditionally exemplified as safe and protected, just like alchohol consumption and smoking, there is growing concern that exposures to harmful chemicals may have an adverse effect on a developing child in the womb (in -utero).

The growth of a baby inside the womb and after birth, is mediated by hormones, such as oestrogens, progesterone, androgens, insulin and thyroid hormone, which are released from endocrine glands (including the placenta) into the bloodstream and transported to different tissues  and organs. For normal growth and development to occur, tissues require specific concentrations of particular hormones at particular times (1). This is why early development is especially susceptible to those chemicals that disrupt the hormone (endocrine) system (so called endocrine disrupting chemicals or EDCs).

Why should we be concerned?

Studies show that EDCs are commonly found in human and animal tissue including the placenta and amniotic fluid (2). For example, BPA is routinely found in blood, amniotic fluid, breast milk and the placenta (3). Phthalates, parabens, synthetic musks (fragrances), pesticides and UV filters (4) have been shown to be present in breast milk, and polychlorinated biphenyls, dioxins and methylmercury in placenta (5).

Studies also show that EDCs can affect the reproductive system of both sexes by interfering with hormones such as testosterone and oestrogens. Studies on wildlife and in the laboratory suggest that foetal exposure to EDCs may result in problems such as deformed reproductive organs and decreased fertility in adult life (6, 7, 8). In human studies, EDCs have been associated with an increase in incidence of endometriosis, infertility and reproductive cancers (9).

Some changes induced by exposure to EDCs during early development may cause permanent alterations that can be passed on to future generations. Such changes may affect “epigenetic” control mechanisms, a means by which cells switch genes on or off, without altering the primary DNA sequence of a gene (10). Diethylstillbestrol (DES), used in the U.S. until the 1970s (and Europe until the 1980s) to help prevent miscarriage, is an example of an oestrogenic EDC which induces epigenetic changes in breast cells (11). In the U.S., daughters of exposed mothers have an increased risk of breast (12) and uterine cancer (13). Similarly, DDT, an insecticide once used widely in the U.S. until its ban in 1972, has been identified as an oestrogenic EDC (14). A recent U.S. study found that women whose mothers had been exposed to significant levels of DDT during pregnancy were four times as likely to have had breast cancer by the age of 52, as woman whose mothers were exposed to small quantities (15).

How are in-utero exposures linked to breast cancer?

There is increasing evidence that in utero exposure to certain EDCs may increase the risk of developing breast cancer later in life. EDCs may delay or inhibit post-natal breast development and cause a lack of response to hormones (16). They may also cause an increase in breast tissue density, a known risk factor in breast cancer, or increase sensitivity of the breast to carcinogens, thereby increasing breast cancer risk following carcinogen exposure (17). Some EDCs bind to oestrogen receptors and mimic the action of natural oestrogens (18). Binding of oestrogens to their receptors results in increased breast cell division which is thought to explain why lifelong exposure to elevated levels of oestrogens is a known breast cancer risk (19). Furthermore, oestrogen metabolites (break-down products) may increase mutations and promote cancer (20).

Prenatal exposure to EDCs no longer in use, such as DES (21) and DDT (22), is associated with increased breast cancer risk. Exposure to elevated levels of certain polychlorinated biphenyls (PCBs), may also be linked to increased breast cancer risk, specifically in young women (23). PCBs were once used widely in electrical insulating fluids and as plasticisers, and, like DDT and its metabolites, are common contaminants of soil and water. Exposure occurs following consumption of contaminated food and water.

Associations between currently used EDCs and an increased breast cancer risk are generally based on extrapolations from animal and cell culture studies. For example, studies in rodents suggest in utero exposure to BPA increases the risk of mammary gland tumours (24); enhances sensitivity of mammary glands to carcinogen-induced tumours (25); could cause epigenetic changes thought to contribute to the development of pre-cancerous and cancerous lesions (26); and may also induce mammary carcinogenesis by binding to oestrogen receptors present in foetal breast tissue (27).  Other EDCs linked to breast cancer risk in animal and cell culture studies include  benzyl butyl phthalate, (commonly used as a plasticiser in PVC plastics) (28), vinclozolin (a pesticide) (29) and methoxychlor (a banned insecticide) (30,31). Exposure to mixtures of common oestrogenic EDCs may also affect mammary gland development (32).

Breast Cancer UK  position:

  • Breast Cancer UK is calling for the Government and NHS advice services to publish a comprehensive guide for pregnant woman which explains the potential risk of in utero environmental exposures and their possible effects on the unborn child,
  • Breast Cancer UK believes greater investment should be directed towards research which helps us to understand the environmental causes of breast cancer in order that we can prevent the disease before it starts.

Find out how to Reduce your Risk

For more information and a full list of reference download our Background briefing on In-Utero Exposures

We would like to thank Dr Michelle Bellingham (University of Glasgow) for her help in the preparation of this information sheet.

References

  1. UNEP/WHO (2013). State of the science of endocrine disrupting chemicals 2012. (Accessed May 26, 2015)
  2. UNEP/WHO (2013), op. cit.
  3. Vandenberg, L. N. et al. (2010). Urinary, Circulating, and Tissue Biomonitoring Studies Indicate Widespread Exposure to Bisphenol A. Environmental Health Perspectives 118 (8): 1055-1070.
  4. Schlumpf, M. et al. (2010). Exposure patterns of UV filters, fragrances, parabens, phthalates, organochlor pesticides, PBDEs, and PCBs in human milk: Correlation of UV filters with use of cosmetics. Chemosphere 81: 1171–1183.
  5. Leino, O. et al. (2013). Pollutant concentrations in placenta. Food and Chemical Toxicology 54: 59-69.
  6. UNEP/WHO (2013), op. cit.
  7. Gross-Sorokin, M. Y. et al. (2006). Assessment of feminization of male fish in English rivers by the Environment Agency of England and Wales. Environmental Health Perspectives 114 (1): 147-51.
  8. EEA (2012). The impacts of endocrine disrupters on wild-life, people and their environments—The Weybridge+15 (1996–2011) report.  (Accessed June 18, 2015)
  9. Diamanti-Kandarakis, E. et al. (2009). Endocrine- disrupting chemicals: an Endocrine Society scientific statement. Endocrine Reviews 30(4): 293-342.
  10. Skinner, M. K. et al. (2011). Epigenetic transgenerational actions of endocrine disruptors. Reproductive Toxicology 31(3): 337-343.
  11. Knower, K. C. et al. (2014). Endocrine disruption of the epigenome: a breast cancer link. Endocrine Related Cancer 21(2): T33-55.
  12. Hilakivi-Clarke, L. (2014). Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters. Breast Cancer Research 16(2): 208.
  13. Smith, E. K. et al. (2012). Higher incidence of clear cell adenocarcinoma of the cervix and vagina among women born between 1947 and 1971 in the United States. Cancer Causes Control 23(1): 207-211.
  14. Kuiper, G. G. et al. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139: 4252-4263.
  15. Cohn, B. A. et al. (2015). DDT Exposure in utero and Breast Cancer. Journal of Clinical Endocrinology and Metabolism Jun 16: jc20151841 [Epub ahead of print]. 
  16. Macon, M. B. and Fenton, S. E. (2013). Endocrine Disruptors and the Breast: Early Life Effects and Later Life Disease. Journal of Mammary Gland Biology and Neoplasia 18: 43-61.
  17. Macon, M. B. and Fenton, S. E. (2013), ibid
  18. Diamanti-Kandarakis, E. et al. (2009), op. cit.
  19. Travis, R. C. and Key, T. J. (2003). Oestrogen exposure and breast cancer risk. Breast Cancer Research 5: 239-247.
  20. Santen, R. J. et al. (2015). Estrogen metabolites and breast cancer. Steroids 99: 61-66.
  21. Knower, K. C, et al. (2014), op. cit.
  22. Cohn, B. A. et al. (2015), op. cit.
  23. Cohn, B. A. et al. (2012). Exposure to polychlorinated biphenyl (PCB) congeners measured shortly after giving birth and subsequent risk of maternal breast cancer before age 50. Breast Cancer Research and Treatment 136(1): 267-275.
  24.  Murray, T. J. (2007). Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure. Reproductive Toxicology 23: 383-390.
  25.  Betancourt, A. M. et al. (2010). In utero Exposure to Bisphenol A Shifts the Window of Susceptibility for Mammary Carcinogenesis in the Rat. Environmental Health Perspectives 118: 1614-1619.
  26. Dhimolea, E. et al. (2014). Prenatal Exposure to BPA Alters the Epigenome of the Rat Mammary Gland and Increases the Propensity to Neoplastic Development. PLoS ONE 9(7): e99800.
  27.  Paulose, T. et al. (2015). Estrogens in the wrong place at the wrong time: Fetal BPA exposure and mammary cancer. Reproductive Toxicology 54: 58-65.
  28. Moral, R. et al. (2001). In utero exposure to butyl benzyl phthalate induces modifications in the morphology and the gene expression profile of the mammary gland: an experimental study in rats. Environmental Health 10: 5.
  29. Nilsson, E. E. et al. (2008). Transgenerational epigenetic effects of the endocrine disruptor vinclozolin on pregnancies and female adult onset disease. Reproduction 135: 713-721.
  30. Murray, K. E. et al. (2010). Prioritizing research for trace pollutants and emerging contaminants in the freshwater environment. Environmental Pollution. 158(12): 3462-3471.
  31. Lee, H. R. et al. (2012). Treatment with bisphenol A and methoxychlor results in the growth of human breast cancer cells and alteration of the expression of cell cycle-related genes, cyclin D1 and p21, via an estrogen receptor-dependent signaling pathway. International Journal of Molecular Medicine 29(5): 883-890.
  32. Mandrup, K. R. et al. (2015). Mixtures of environmentally relevant endocrine disrupting chemicals affect mammary gland development in female and male rats. Reproductive Toxicology 54: 47-57

Last updated June 20, 2017

Did you find this article useful?

1 2 3 4 5
This entry has not been rated yet.

Help us prevent breast cancer Make a donation now